Skip to product information
1 of 2

R&R Innovations

GW 1516

GW 1516

Regular price $61.79 USD
Regular price $69.99 USD Sale price $61.79 USD
Sale Sold out
Shipping calculated at checkout.

GW501516 (also known as Cardarine, Endurobol, or GW1516) is a synthetic metabolic modulator and selective PPARδ receptor agonist developed in the 1990s by Ligand Pharmaceuticals and GlaxoSmithKline. 

Overview and Purpose
  • Development History: Originally investigated to treat metabolic and cardiovascular conditions, such as obesity, diabetes, and high cholesterol. 
  • Discontinuation: Clinical development was abandoned in 2007 because animal testing revealed rapid and widespread cancer induction across multiple organs.
  • Classification: It is not a steroid or a SARM (Selective Androgen Receptor Modulator), though it is frequently misadvertised as one. It functions as an exercise mimetic that shifts energy usage toward fatty acid metabolism. 
View full details